Company Search:
Advanced Search
Sponsored Links
Tellgen Corp Company Snapshot
Tellgen Corp operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tellgen Corp with three other companies in this sector in China: BioSino Bio-technology and Science Inc (2017 sales of 295.13 million Chinese Renmimbi [US$43.58 million] ), Guangdong Hybribio Biotech Co Ltd (479.09 million Chinese Renmimbi [US$70.74 million] of which 97% was Monitoring Instrument), and Getein Biotech Inc (488.58 million Chinese Renmimbi [US$72.14 million] of which 99% was In-vitro diagnostics).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Tellgen Corp
  Stock Performance Chart for Tellgen Corp
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 37.90
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 1.8%  
4 Weeks -23.3%   52 Weeks -32.5%  
Tellgen Corp Key Data:
  Ticker: 300642 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2017 Sales 302,888,219
(Year Ending Jan 2018).
Employees: 313
  Currency: Chinese Renmimbi Market Cap: 3,442,955,385
  Fiscal Yr Ends: December Shares Outstanding: 90,843,150
  Share Type: A GU Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.